Literature DB >> 16342646

Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR.

Rinaldo Bellomo, Moritoki Egi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16342646     DOI： 10.4065/80.12.1546

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  18 in total

1.  Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill?

Authors:  P E Cryer
Journal:  Diabetologia       Date:  2006-08       Impact factor: 10.122

2.  What is a NICE-SUGAR for patients in the intensive care unit?

Authors:  Rinaldo Bellomo; Moritoki Egi
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

3.  Uncovering the predictive value of minimum blood glucose through statistical analysis of a large clinical dataset.

Authors:  Ying Zhang; Michael S C Hemond
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

Review 4.  Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

Review 5.  Ethics and research in critical care.

Authors:  Henry J Silverman; Francois Lemaire
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

Review 6.  Is management of hyperglycaemia in acute phase stroke still a dilemma?

Authors:  C Savopoulos; G Kaiafa; I Kanellos; A Fountouki; D Theofanidis; A I Hatzitolios
Journal:  J Endocrinol Invest       Date:  2016-11-21       Impact factor: 4.256

Review 7.  Perioperative blood glucose monitoring in the general surgical population.

Authors:  Tejal A Raju; Marc C Torjman; Michael E Goldberg
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 8.  [Adjuvant treatment of sepsis: what is known?].

Authors:  C J Wiedermann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-22       Impact factor: 0.840

9.  Current status of tight blood sugar control.

Authors:  Jean-Charles Preiser; Philippe Devos
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

10.  Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?

Authors:  Moritoki Egi; Rinaldo Bellomo; Michael C Reade
Journal:  Crit Care       Date:  2009-04-06       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.